Whalesbook
Strong Q4 Performance and Expansion Plans
Himadri Specialty Chemical posted a strong 28.3% year-over-year increase in gross profit for the fourth quarter of fiscal year 2026. This was partly offset by a INR 0.4 billion forex loss that affected earnings before interest, taxes, depreciation, and amortization (EBITDA). The company reported consolidated revenues of INR 12,877.6 million for the quarter, contributing to a full-year revenue of INR 46,607 million. Management expects fiscal year 2027 to benefit from the full ramp-up of its recently commissioned specialty carbon black plant. Further down its growth path, Himadri plans to commission a new chemicals plant in Q3 FY27 and advance its battery materials segment with pilot plants to secure future contracts from FY28. A key financial highlight is the company's strengthened balance sheet, which now shows a net cash position of INR 1.21 billion as of March 31, 2026, offering financial flexibility for future investments.
Premium Valuation and Analyst Concerns
Despite these positive operational and financial developments, analysts largely maintain a cautious 'HOLD' recommendation. ICICI Securities raised its EBITDA estimates for FY27/28 by 16-25% and adjusted its sum-of-the-part based target price to INR 550 from INR 470, applying a 15x EV/EBITDA multiple to the core business. This move reflects optimism about the 'others' segment's profitability. However, other analyst consensus targets remain around INR 470, suggesting a potential downside from current trading levels near INR 570-600. Himadri Specialty Chemical's trailing twelve-month (TTM) P/E ratio is over 37x, significantly higher than global peers such as Cabot Corporation (around 13.25x) and Reliance Industries (around 22-24x). This premium valuation indicates that substantial future growth is already priced in, potentially limiting upside from current levels. Separately, MarketsMOJO issued a 'Sell' rating in March 2026, citing technical indicators.
Risks: Execution and Macro Pressures
Several factors underpin the cautious outlook. The company's operating profit margins, excluding other income, dipped to 18.77% in Q4 FY26 from 20.56% a year earlier, pointing to potential cost pressures. Additionally, the interest burden nearly doubled year-on-year to INR 17.39 crore in Q4 FY26, affecting the interest coverage ratio. Analysts also flag concerns about the company's reliance on debt for ambitious expansion plans, a risk that could grow if profitability falters. The broader geopolitical climate, particularly the Middle East crisis, adds layers of uncertainty. While Himadri management claims structural insulation from the conflict, it has demonstrably driven up input costs for commodity chemicals like naphtha, ethylene, and benzene. It has also increased freight and insurance expenses due to disruptions in critical shipping routes, such as the Strait of Hormuz. This volatility in raw material prices and logistics directly impacts chemical manufacturers' margins. The INR 0.4 billion forex loss reported in Q4 FY26 serves as a tangible reminder of these external economic pressures.
Sector Position and Growth Prospects
Despite valuation concerns and macro risks, Himadri Specialty Chemical is strategically positioned within India's burgeoning specialty chemicals market, projected to reach $93.4 billion by 2034. The company is significantly expanding its specialty carbon black capacity, establishing what it claims is the world's largest single-location facility with a total capacity of 250,000 MTPA. This expansion targets high-value applications in batteries, plastics, and conductive materials. Its venture into battery materials, including an operational anode production facility and plans for a significant LFP cathode active material project, aligns with the global shift towards electric vehicles and energy storage. Himadri also holds a dominant position in India's coal tar pitch market and is a key player in naphthalene and SNF. The company's consistent stock performance, delivering a 26.21% return over the past year and outperforming the broader market, shows investor confidence in its long-term growth narrative. However, analysts maintain a measured approach to its current valuation.